DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy

Overview of attention for article published in Frontiers in Cell and Developmental Biology, March 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

COMBINATIONS OF DGK (DIACYLGLYCEROL KINASE) INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS…

Application WO-2024165469-A1

World Intellectual Property Organisation (WIPO)

COMBINATIONS OF DGK (DIACYLGLYCEROL KINASE) INHIBITORS

Application WO-2024165470-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.